📑Dostavka na medikamenti: lekarstveni produkti, konsumativi, serumi i testove po obosobeni pozicii.
Procurement process summary
This process is to purchase Dostavka na medikamenti: lekarstveni produkti, konsumativi, serumi i testove po obosobeni pozicii.
This contract was awarded by 🇧🇬 МИНИСТЕРСТВО НА ОТБРАНАТА for an amount of BGN 15,807 to 1 supplier. It was published on not reported through selective
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇧🇬 МИНИСТЕРСТВО НА ОТБРАНАТА Buying unitnot reported Publication datenot reported Contest statusnot reported Descriptionnot reportedAwards
This award was granted to "ЦИТО КЪМПАНИ" ООД by МИНИСТЕРСТВО НА ОТБРАНАТА for an amount of BGN 15,807. The procurement process was conducted through selective for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇧🇬 "ЦИТО КЪМПАНИ" ООД | BGN 15,807 | 1 |
Market context and opportunities
The execution of this contract allows the entity МИНИСТЕРСТВО НА ОТБРАНАТА to fulfill its public service objectives efficiently.
The selective purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberBG_ocds-70d2nz-7e1e783c-d8d1-403c-9c3f-b0a2cdbdd83c-award-1Publication datenot reportedContract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityselectiveMethod detailsДоговаряне с поканаStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
